Research Article
Increased Circulating CD4+CXCR5+ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases
Table 1
The characteristics of MDS patients with autoimmune diseases.
| | MDS-AI | MDS-NAI | |
| Number | 21 | 21 | | Age (years) | 49 (20-87) | 53 (21-83) | 0.4503 | Sex (male/female) | 8/13 | 11/10 | 0.5359 | MDS subtype | | | 0.8596 | MDS-SLD | 3 | 4 | | MDS-MLD | 6 | 5 | | MDS-RS | 0 | 1 | | MDS-EB1 | 7 | 6 | | MDS-EB2 | 5 | 5 | | IPSS-R | | | 0.9370 | Very low | 2 | 3 | | Low | 5 | 5 | | Intermediate | 5 | 5 | | Poor | 4 | 5 | | Very poor | 5 | 3 | | Karyotype | | | 0.8874 | Very good | 1 | 0 | | Good | 14 | 14 | | Intermediate | 3 | 4 | | Poor | 2 | 2 | | Very poor | 1 | 1 | | Median BM blasts (%) | 5.5 (0-19) | 6 (0-19) | 0.9247 |
|
|
MDS-AI: MDS with autoimmune disease; MDS-NAI: MDS without autoimmune disease; BM: bone marrow.
|